Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glide Pharmaceutical

Glide Pharmaceutical
2001 FOUNDED
OOB STATUS
21-30 EMPLOYEES
Bankr. Admin/Reorg LATEST DEAL TYPE
Description

Developer of a pharmaceutical development and device platform designed to offer needle-free injectors. The company's platform focuses on the needle-free administration of solid dose formulation of therapeutics and vaccines, that includes octreotide, teriparatide, exenatide and anthrax and influenza vaccines, enabling physicians improve treatment experiences of both patients and carers.

Formerly Known As
Caretek Medical
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • 45B/C Western Avenue
  • Milton Park, Abingdon
  • Oxfordshire OX14 4RU
  • England, United Kingdom

+44 01235 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Glide Pharmaceutical’s full profile, request a free trial.

Glide Pharmaceutical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Admin/Reorg 31-Aug-2017 Completed Bankruptcy: Admin/Reorg
9. Later Stage VC 01-Feb-2017 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 12-Mar-2013 000.00 000.00 000.00 Completed Generating Revenue
7. Grant 05-Nov-2012 00.000 000.00 Completed Generating Revenue
6. Grant 01-Jun-2012 00000 000.00 Completed Generating Revenue
5. Later Stage VC 10-Feb-2010 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 23-Oct-2008 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 13-Aug-2007 00.000 00.00 Completed Generating Revenue
2. Early Stage VC 06-Dec-2005 $3.63M $4.68M Completed Startup
1. Early Stage VC 24-Mar-2005 $1.05M $1.05M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Glide Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
A Ordinary 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 4 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 3 000,000 00.000000 00.0 00.0 00 00.0 0.000
Ordinary 2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 1 274,870 $0.000152 $7.63 $7.63 1x $7.63 2.8%
B Ordinary 42,956 $0.000152 $7.07 $7.07 1x $7.07 0.44%
To view this company’s complete Cap Table, request access »

Glide Pharmaceutical Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 000000 Formerly VC-backed Fremont, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Glide Pharmaceutical Executive Team (10)

Name Title Board
Seat
Contact
Info
Mark Carnegie-Brown Ph.D Chief Executive Officer & Board Member
James Otter Interim Chief Executive Officer
Imogen Collis Chief Scientific Officer
Genevieve Motte Ph.D Director, Development & Operations
Tony Mills Ph.D Chief Business Officer

3 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Glide Pharmaceutical Board Members (7)

Name Representing Role Since Contact
Info
Bryan Morton Self Chairman 000 0000
Mark Carnegie-Brown Ph.D Glide Pharmaceutical Chief Executive Officer & Board Member 000 0000
Richard Bungay Self Board Member 000 0000

4 Former Board Members

You’re viewing 3 of 7 board members. Get the full list »